140 related articles for article (PubMed ID: 20635170)
1. Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11263 subjects.
Cao C; Ying T; Fang JJ; Sun SF; Lv D; Chen ZB; Ma HY; Yu YM; Ding QL; Shu LH; Deng ZC
Med Oncol; 2011 Dec; 28(4):1169-75. PubMed ID: 20635170
[TBL] [Abstract][Full Text] [Related]
2.
Mahajan D; Sambyal V; Uppal MS; Sudan M; Guleria K
Genet Test Mol Biomarkers; 2024 May; 28(5):176-188. PubMed ID: 38597641
[TBL] [Abstract][Full Text] [Related]
3. Relationship between vascular endothelial growth factor -2578C > a gene polymorphism and lung cancer risk: a meta-analysis.
Zhao HL; Yu JH; Huang LS; Li PZ; Lao M; Zhu B; Ou C
BMC Med Genet; 2020 Jan; 21(1):17. PubMed ID: 31996156
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor -634G/C and vascular endothelial growth factor -2578C/A polymorphisms and lung cancer risk: a case-control study and meta-analysis.
Deng ZC; Cao C; Yu YM; Ma HY; Ye M
Tumour Biol; 2014 Mar; 35(3):1805-11. PubMed ID: 24146275
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor +405G/C and -2578C/A polymorphisms and breast cancer risk: a meta-analysis.
Zhang Y; Yu YF; Wang JZ; Jia H
Genet Mol Res; 2015 Aug; 14(3):8909-18. PubMed ID: 26345822
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF) -2578C/A and -460C/T gene polymorphisms and lung cancer risk: a meta-analysis involving 11 case-control studies.
Song N; Liu B; Wu J; Zhang R; Duan L; He W; Zhang C
Tumour Biol; 2014 Jan; 35(1):859-70. PubMed ID: 23982876
[TBL] [Abstract][Full Text] [Related]
7. Association between VEGF Gene Polymorphisms and the Susceptibility to Lung Cancer: An Updated Meta-Analysis.
Yang F; Qin Z; Shao C; Liu W; Ma L; Shu Y; Shen H
Biomed Res Int; 2018; 2018():9271215. PubMed ID: 30013987
[TBL] [Abstract][Full Text] [Related]
8. Four common vascular endothelial growth factor polymorphisms (-2578C>A, -460C>T, +936C>T, and +405G>C) in susceptibility to lung cancer: a meta-analysis.
Lin L; Cao K; Chen W; Pan X; Zhao H
PLoS One; 2013; 8(10):e75123. PubMed ID: 24098368
[TBL] [Abstract][Full Text] [Related]
9. Associations between vascular endothelial growth factor polymorphisms and prostate cancer risk: a meta-analysis.
Xu Y; Zhu S
Tumour Biol; 2014 Feb; 35(2):1307-11. PubMed ID: 24127038
[TBL] [Abstract][Full Text] [Related]
10. Association between VEGF gene promoter polymorphisms and bladder cancer: An updated meta-analysis.
Chen CH; Ho CH; Kuan-Hua Huang S; Shen CH; Wu CC; Wang YH
Cytokine; 2020 Jul; 131():155112. PubMed ID: 32361400
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor +936C/T, -634G/C, -2578C/A, and -1154G/A polymorphisms with risk of preeclampsia: a meta-analysis.
Cheng D; Hao Y; Zhou W; Ma Y
PLoS One; 2013; 8(11):e78173. PubMed ID: 24223772
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of DNA methyltransferase 3B -149C/T and cancer risk: a meta-analysis.
Zhu J; Du S; Zhang J; Wang Y; Wu Q; Ni J
Med Oncol; 2015 Jan; 32(1):399. PubMed ID: 25433949
[TBL] [Abstract][Full Text] [Related]
13. Polymorphism of vascular endothelial growth factor -1154G>A (rs1570360) with cancer risk: a meta-analysis of 16 case-control studies.
Hong TT; Zhang RX; Wu XH; Hua D
Mol Biol Rep; 2012 May; 39(5):5283-9. PubMed ID: 22167330
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor -2578C/A polymorphism and colorectal cancer risk: A meta-analysis.
Wang L; Ji S; Cheng Z
J Res Med Sci; 2015 Aug; 20(8):811-7. PubMed ID: 26664430
[TBL] [Abstract][Full Text] [Related]
15. Association of the vascular endothelial growth factor -2578C/A polymorphism with cancer risk: A meta-analysis update.
Chen Q; Zhou Z; Shan L; Hua Y; Zeng H; Liu P; Cai Z
Biomed Rep; 2014 Nov; 2(6):823-830. PubMed ID: 25279153
[TBL] [Abstract][Full Text] [Related]
16. The Protective Effects of the VEGF -2578C>A and -1154G>A Polymorphisms Against Hypertension Susceptibility.
Kim YR; Hong SH
Genet Test Mol Biomarkers; 2015 Sep; 19(9):476-80. PubMed ID: 26154735
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor (VEGF) gene polymorphisms and colorectal cancer: a meta-analysis of epidemiologic studies.
Zhao Z; Ba C; Wang W; Wang X; Xue R; Wu X
Genet Test Mol Biomarkers; 2012 Dec; 16(12):1390-4. PubMed ID: 23005896
[TBL] [Abstract][Full Text] [Related]
18. Three Polymorphisms of Vascular Endothelial Growth Factor (+936C > T, -460C > T, and -2578C > A) and Their Susceptibility to Ovarian Cancer: A Meta-Analysis.
Zhang X; Qin J; Qin A
Int J Gynecol Cancer; 2015 Jun; 25(5):779-85. PubMed ID: 25835351
[TBL] [Abstract][Full Text] [Related]
19. Potential Impact of Vascular Endothelial Growth Factor Gene Variation (-2578C>A) on Breast Cancer Susceptibility in Saudi Arabia: a Case-Control Study.
Al Balawi IA; Mir R; Abu-Duhier FM
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1135-1143. PubMed ID: 29699375
[TBL] [Abstract][Full Text] [Related]
20. Association of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer risk.
Jaiswal PK; Tripathi N; Shukla A; Mittal RD
Med Oncol; 2013 Jun; 30(2):509. PubMed ID: 23430447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
